Updated on:2025-03-07

Updated on:2025-03-01

On February 28, the ChiHeal Bio , Taikang Xianlin Gulou Hospital, and Shijiazhuang Diskeyway held the \"Strategic Cooperation Signing Ceremony and Academic Seminar\" at the Taikang Xianlin Gulou Hospital Phase II. The three parties engaged in deep cooperation, marking not only an academic feast that blends traditional Chinese and Western medicine but also an innovative practice of integrating industry, academia, and research.

Updated on:2025-03-01

ChiHeal Bio Special Forum Successfully Held in Nanjing, Gathering Industry Experts to Explore Future Innovations On February 27, 2025, the ChiHeal Bio Special Forum was successfully held at the Fengda International Hotel in Nanjing. Under the theme “Focusing on Innovation, Analyzing Policy Concepts, and Shaping the Future of Enterprises,” the event attracted numerous industry experts, scholars, and business leaders. Together, they explored cutting-edge trends and emerging opportunities in the ph

Updated on:2025-02-18

As an innovative enterprise deeply engaged in the pharmaceutical CRO field, Chihealbio has always been committed to providing the industry with a full range of services covering the development of innovative drugs, improved new drugs, and generic drugs.

Updated on:2025-02-17

in the midst of the surging wave of technological advancements, artificial intelligence is reshaping the future of various industries at an unprecedented speed.

Updated on:2025-02-13

On February 12, 2025, Chihealbio Group held the 2025 Annual Work Mobilization Meeting at the beginning of the New Year. Dr. Zhang Zhefeng, Chairman of the Group, Mr. Hou Junqi, Vice President of Operations, Ms. Hou Wen, Vice President of the Group, along with middle management from various subsidiaries, participated in the meeting.

Updated on:2025-02-08

This year, 21 products were added under the B certificate, and 3 products with 4 product numbers passed GMP compliance inspections and obtained inspection notices.

Updated on:2025-02-08

Chiheal (Shandong) Pharma has navigated a busy and fulfilling 2024.

Updated on:2025-02-08

As winter plum blossoms bloom and the twelfth lunar month welcomes spring, Chiheal Group held its senior management business conference on January 24, 2025.

Updated on:2025-02-08

In the past year, Beijing Chiheal Aikang Pharma, as a core force of the registration and clinical business segment of Chiheal Group, achieved significant results.

Updated on:2025-02-08

In 2024, Discovery Pharma achieved excellent results across various departments.

Updated on:2025-02-08

As the winter deepens and the winter plum blossoms bloom, another year passes with the shifting of the stars.

Updated on:2025-01-09

Nanjing Chiheal Bio Medicine Technology Co., Ltd successfully passed the evaluation for the national Specialized, Refined, Characteristic, and Innovative (Little giants) enterprise, thanks to its comprehensive corporate strength, and was granted the title of……

Updated on:2023-05-16

Since its establishment in 2018, Chiheal Pharmaceutical Group has adhered to the principles of being clinically demand-driven, innovation-focused, and customer-centered. Through high-quality, efficient, and cost-effective research and development services, the company has helped clients seize timely opportunities related to consistency evaluation, MAH new policies, and centralized procurement. This has empowered the development and growth of partner enterprises, enabling all parties to achieve r

Updated on:2022-09-27

On September 9, 2022, during the 2nd China Pharmaceutical Distribution and Trade Conference and the 2nd World Pharmaceutical Retail Conference, the Xingchen Capital Forum, sponsored by Hongjitang, was successfully held.